Agranulocytosis during treatment with mianserin and venlafaxine.
Lucht
M J
MJ
Kleinschmidt
R
R
Maier
W
W
Rietschel
M
M
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008803:Mianserin / Q000009:adverse effects* / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D008803:Mianserin; D000069470:Venlafaxine Hydrochloride